ASCO

News

Venetoclax-Based Time-Limited Therapy Well Tolerated, Effective in CLL

06/10/2020

Zanubrutinib plus venetoclax and obinutuzumab is well tolerated and achieves rapid undetectable minimal residual disease (MRD) in patients with chronic lymphocytic leukemia (CLL), according to a presentation at the...

...

06/10/2020

Journal of Clinical Pathways

News

Impact of NGS on Treatment Selection in AML

06/08/2020

Next-generation sequencing (NGS) has the potential to directly impact treatment decisions and outcomes in patients with acute myeloid leukemia (AML), according to a study presented at the American Society of Clinical...

...

06/08/2020

Journal of Clinical Pathways

News

Final Results of KEYNOTE-100 for Patients With Advanced Ovarian Cancer

06/03/2020

Pembrolizumab monotherapy continues to show modest antitumor activity in patients with recurrent advanced ovarian cancer, according to updated results of the KEYNOTE-100 study presented at the American Society of...

...

06/03/2020

Journal of Clinical Pathways

News

Utility of Genomic Instability Test Scores for Predicting PARP Response in Ovarian Cancer

06/03/2020

HRD test results used in published and ongoing clinical trials for PARP inhibitor-treatment of ovarian cancer are not equivalent, according to the results of a study presented at the American Society of Clinical...

HRD...

06/03/2020

Journal of Clinical Pathways

News

First Ever Oncology Hospital-At-Home Evaluation Shows Better Outcomes, Lower Costs

06/02/2020

The first ever reported trial of an adult oncology hospital-at-home program shows strong evidence for reduced hospitalizations, ED visits, and costs, according to a presentation at the American Society of Clinical...

The...

06/02/2020

Journal of Clinical Pathways

News

Impact of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer

06/01/2020

On the first day of the American Society of Clinical Oncology (ASCO) Annual Meeting (May 30, 2020), Helen MacKay, MBChB, BSc, MRCP, MD, department of medicine, University of Toronto, provided the context and...

On the...

06/01/2020

Journal of Clinical Pathways

News

Highlighting Research on Health Services Utilization, Quality Improvement Efforts

05/31/2020

At the American Society of Clinical Oncology (ASCO) Annual Meeting (May 29-31, 2020), Stewart B Fleishman, MD, Coachella Valley Volunteers in Medicine (Indio, CA), highlighted three abstracts presented at the meeting...

At the...

05/31/2020

Journal of Clinical Pathways

News

Practice-Changing Clinical Trials in Metastatic Colorectal Cancer

05/30/2020

Autumn J McRee, MD, associate professor of medicine, The University of North Carolina at Chapel Hill, presented on three clinical studies of targeted therapies in unique niches of metastatic colorectal cancer. The...

Autumn...

05/30/2020

Journal of Clinical Pathways

News

At-Home PROs Offer Effective Approach for QoL Monitoring in Prostate Cancer Trials

05/30/2020

At the American Society of Clinical Oncology (ASCO) Annual Meeting (May 29-31, 2020), researchers from ERT—a global data and technology company that helps minimize risk in clinical trials—shed light on the...

At the...

05/30/2020

Journal of Clinical Pathways

News

Clinical Pathways Reduce Cost, Increase Clinical Trial Entry for Patients With NSCLC

05/28/2020

A study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting (May 29-31, 2020) demonstrated how standardized evidence-based clinical pathways can be used successfully across a large number of...

A...

05/28/2020

Journal of Clinical Pathways